1 / 3

Intermittent DNA Vaccination Study on A20 Lymphoma Mice

This study explores the effects of intermittent DNA vaccination on A20 Lymphoma in mice over 35 days, with dosage variations and Lenalidomide treatment.

hailey
Télécharger la présentation

Intermittent DNA Vaccination Study on A20 Lymphoma Mice

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figure 1 a b c a continuous schedule for 35 consecutive days an intermittent schedule DNA vaccination (50 ug/mouse) DNA vaccination (50 ug/mouse) A20 Lymphoma A20 Lymphoma Day Day 1 35 0 14 28 0 14 28 42 21 18 35 42 32 7 4 Lenalidomide: 5 or 50 mg/kg i.p. for 35 consecutive days Lenalidomide: 5 or 50 mg/kg i.p.

  2. Supplementary Figure 2

  3. Supplementary Figure 3

More Related